Hemophilia

Gene therapy may help to improve blood clotting for bleeding disorder

Published in Gene Therapy Weekly, April 4th, 2002

Researchers are advancing on the goal of successfully using gene therapy to treat the crippling bleeding disorder hemophilia, according to Katherine A. High, MD, a hematologist at the Children's Hospital of Philadelphia and one of the world's preeminent experts in the field of gene therapy.

Dr. High is currently involved in clinical trials seeking to improve blood clotting in patients with hemophilia B by using a genetically engineered virus to deliver beneficial genes. High delivered a Science Innovation Lecture to the American Association for the Advancement of Science recently in Boston.

"While current clinical studies look promising," she said,...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Gene Therapy Weekly

Source: Gene Therapy Weekly (2002-04-04)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry